{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"102"}],"units":"Participants"}],"description":"Survival status was assessed 5 years after transplant.","groups":[{"description":"Cyclophosphamide + etoposide + melphalan + carmustine with filgrastim","id":"OG000","title":"High-Dose Sequential Therapy"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"5 years","title":"Overall Participant Survival (OS)","type":"SECONDARY","unitOfMeasure":"Participants"}